Nyrada Inc - Annual Report 2024

NYRADA INC (ASX:NYR) 12 “Subject to the successful completion of GLP studies, Nyrada remains on track to commence its first-in-human Phase I clinical trial for NYR-BI03 late in this calendar year.”

RkJQdWJsaXNoZXIy MjE2NDg3